实用心脑肺血管病杂志
實用心腦肺血管病雜誌
실용심뇌폐혈관병잡지
Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
2015年
10期
25-28
,共4页
心力衰竭%曲美他嗪%心肌能量消耗%心室重构
心力衰竭%麯美他嗪%心肌能量消耗%心室重構
심력쇠갈%곡미타진%심기능량소모%심실중구
Heart failure%Trimetazidine%Myocardial energy expenditure%Ventricular remodeling
目的:探讨曲美他嗪对缺血性心力衰竭患者心肌能量消耗(MEE)水平的影响及其与左心室重构的关系。方法选择2012年5月—2014年1月在黄石市第二医院心内科住院治疗的缺血性心力衰竭患者73例,按照随机数字表法分为观察组37例和对照组36例。两组患者均给予冠心病和心力衰竭二级预防常规药物治疗,观察组患者联合曲美他嗪治疗,两组疗程均为12个月。比较两组患者治疗前后左心室结构指标〔左心室收缩末期内径( LVIDs)、左心室质量(LVM)及左心室质量指数(LVMI)〕、左心室射血分数(LVEF)、MEE 及氨基末端脑钠肽前体( NT -proBNP)水平,并分析 MEE 水平与 LVEF、LVMI、NT - proBNP 的相关性。结果治疗前两组患者 LVIDs、LVM 及LVMI 比较,差异均无统计学意义(P ﹥0.05);治疗后观察组患者 LVIDs、LVM 及 LVMI 低于对照组(P ﹤0.01)。治疗前两组患者 LVEF、MEE 及 NT - proBNP 水平比较,差异均无统计学意义(P ﹥0.05);治疗后观察组患者 LVEF 高于对照组,MEE 及 NT - proBNP 水平低于对照组(P ﹤0.05)。Pearson 相关性分析结果显示,MEE 水平与 LVMI、NT -proBNP 水平呈正相关(r 值分别为0.319、0.561,P ﹤0.001),与 LVEF 呈负相关(r =-0.442,P ﹤0.001)。结论曲美他嗪可能通过降低缺血性心力衰竭患者 MEE 水平而抑制左心室重构,从而改善患者心功能。
目的:探討麯美他嗪對缺血性心力衰竭患者心肌能量消耗(MEE)水平的影響及其與左心室重構的關繫。方法選擇2012年5月—2014年1月在黃石市第二醫院心內科住院治療的缺血性心力衰竭患者73例,按照隨機數字錶法分為觀察組37例和對照組36例。兩組患者均給予冠心病和心力衰竭二級預防常規藥物治療,觀察組患者聯閤麯美他嗪治療,兩組療程均為12箇月。比較兩組患者治療前後左心室結構指標〔左心室收縮末期內徑( LVIDs)、左心室質量(LVM)及左心室質量指數(LVMI)〕、左心室射血分數(LVEF)、MEE 及氨基末耑腦鈉肽前體( NT -proBNP)水平,併分析 MEE 水平與 LVEF、LVMI、NT - proBNP 的相關性。結果治療前兩組患者 LVIDs、LVM 及LVMI 比較,差異均無統計學意義(P ﹥0.05);治療後觀察組患者 LVIDs、LVM 及 LVMI 低于對照組(P ﹤0.01)。治療前兩組患者 LVEF、MEE 及 NT - proBNP 水平比較,差異均無統計學意義(P ﹥0.05);治療後觀察組患者 LVEF 高于對照組,MEE 及 NT - proBNP 水平低于對照組(P ﹤0.05)。Pearson 相關性分析結果顯示,MEE 水平與 LVMI、NT -proBNP 水平呈正相關(r 值分彆為0.319、0.561,P ﹤0.001),與 LVEF 呈負相關(r =-0.442,P ﹤0.001)。結論麯美他嗪可能通過降低缺血性心力衰竭患者 MEE 水平而抑製左心室重構,從而改善患者心功能。
목적:탐토곡미타진대결혈성심력쇠갈환자심기능량소모(MEE)수평적영향급기여좌심실중구적관계。방법선택2012년5월—2014년1월재황석시제이의원심내과주원치료적결혈성심력쇠갈환자73례,안조수궤수자표법분위관찰조37례화대조조36례。량조환자균급여관심병화심력쇠갈이급예방상규약물치료,관찰조환자연합곡미타진치료,량조료정균위12개월。비교량조환자치료전후좌심실결구지표〔좌심실수축말기내경( LVIDs)、좌심실질량(LVM)급좌심실질량지수(LVMI)〕、좌심실사혈분수(LVEF)、MEE 급안기말단뇌납태전체( NT -proBNP)수평,병분석 MEE 수평여 LVEF、LVMI、NT - proBNP 적상관성。결과치료전량조환자 LVIDs、LVM 급LVMI 비교,차이균무통계학의의(P ﹥0.05);치료후관찰조환자 LVIDs、LVM 급 LVMI 저우대조조(P ﹤0.01)。치료전량조환자 LVEF、MEE 급 NT - proBNP 수평비교,차이균무통계학의의(P ﹥0.05);치료후관찰조환자 LVEF 고우대조조,MEE 급 NT - proBNP 수평저우대조조(P ﹤0.05)。Pearson 상관성분석결과현시,MEE 수평여 LVMI、NT -proBNP 수평정정상관(r 치분별위0.319、0.561,P ﹤0.001),여 LVEF 정부상관(r =-0.442,P ﹤0.001)。결론곡미타진가능통과강저결혈성심력쇠갈환자 MEE 수평이억제좌심실중구,종이개선환자심공능。
Objective To investigate the impact of trimetazidine on myocardial energy expenditure(MME)level and its correlation with left ventricular reconstitution of patients with ischemic heart failure. Methods From May 2012 to January 2014,a total of 73 inpatients with ischemic heart failure were selected in the Department of Cardiology,the Second Hospital of Huangshi,and they were divided into control group( n = 36) and observation group( n = 37) according to random number table. Patients of both groups received conventional medical treatment and secondary prevention for coronary heart disease and heart failure,while patients of observation group received extra trimetazidine,both groups treated for 12 months. LVIDs,LVM, LVMI,LVEF,MEE level and NT - proBNP level were compared between the two groups before and after treatment,and correlation between MEE level and LVEF,LVMI,NT - proBNP was respectively analyzed. Results No statistically significant differences of LVIDs,LVM or LVMI was found between the two groups before treatment(P ﹥ 0. 05);while LVIDs,LVM and LVMI of observation group were statistically significantly lower than those of control group(P ﹤ 0. 01). No statistically significant differences of LVEF,MEE level or NT - proBNP level was found between the two groups before treatment(P ﹥ 0. 05);after treatment,LVEF of observation group was statistically significantly higher than that of control group,MEE level and NT -proBNP level of observation group were statistically significantly lower than those of control group ( P ﹤ 0. 05 ). Pearson correlation analysis showed that,MEE level was positively correlated with LVMI(r = 0. 319,P ﹤ 0. 001),NT - proBNP level (r = 0. 561,P ﹤ 0. 001),while MEE level was negatively correlated with LVEF(r = - 0. 442,P ﹤ 0. 001). Conclusion Trimetazidine may inhibit left ventricular reconstitution of patients with ischemic heart failure through reducing of MEE level, consequently improve the cardiac function.